PERITONEAL MESOTHELIOMA
Clinical trials for PERITONEAL MESOTHELIOMA explained in plain language.
Never miss a new study
Get alerted when new PERITONEAL MESOTHELIOMA trials appear
Sign up with your email to follow new studies for PERITONEAL MESOTHELIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Hope for rare cancers: new immunotherapy combo trial launches
Disease control Recruiting nowThis study tests a combination of two immunotherapy drugs (domvanalimab and zimberelimab) in 154 people with five types of rare advanced cancers that have stopped responding to standard treatments. The goal is to see if this treatment can control the cancer for at least 24 weeks.…
Matched conditions: PERITONEAL MESOTHELIOMA
Phase: PHASE2 • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated May 17, 2026 01:59 UTC
-
Lab-Grown tumor models could personalize mesothelioma treatment
Disease control Recruiting nowThis study tests a new way to choose cancer treatments for people with peritoneal mesothelioma. After surgery, a small piece of the tumor is grown in the lab to create a model. Different drugs are tested on this model to find the best one for each patient. The goal is to see if t…
Matched conditions: PERITONEAL MESOTHELIOMA
Phase: NA • Sponsor: Beijing Tsinghua Chang Gung Hospital • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New drug combo targets genetic weakness in tough cancers
Disease control Recruiting nowThis early-stage study is testing a new drug, IDE892, both alone and in combination with another drug called IDE397. It is for adults with advanced solid tumors that have a specific genetic change called MTAP deletion and have stopped responding to standard treatments. The main g…
Matched conditions: PERITONEAL MESOTHELIOMA
Phase: PHASE1 • Sponsor: IDEAYA Biosciences • Aim: Disease control
Last updated Apr 15, 2026 16:15 UTC
-
Lab-Grown tumors could guide heated chemo during surgery
Knowledge-focused Recruiting nowThis study aims to see if lab-grown tumor models can predict how well heated chemotherapy (HIPEC) works during surgery for cancers that have spread to the abdomen. About 60 adults whose tumors cannot be fully removed safely will take part. Researchers will compare tumor responses…
Matched conditions: PERITONEAL MESOTHELIOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 07, 2026 18:40 UTC